Home/Filings/4/0001683168-24-002283
4//SEC Filing

Charles Faith L. 4

Accession 0001683168-24-002283

CIK 0001729427other

Filed

Apr 9, 8:00 PM ET

Accepted

Apr 10, 9:50 PM ET

Size

7.9 KB

Accession

0001683168-24-002283

Insider Transaction Report

Form 4
Period: 2024-04-08
Transactions
  • Award

    Option to purchase common stock

    2024-04-08+17,50047,315 total
    Exercise: $0.26Exp: 2034-04-08Common Stock (17,500 underlying)
  • Award

    Restricted Stock Units

    2024-04-08+17,50064,815 total
    Common Stock (17,500 underlying)
Footnotes (3)
  • [F1]The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date.
  • [F2]The awards were issued in connection with the reporting person's Board of Director services to the Company.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of the Company common stock.

Documents

1 file

Issuer

CNS Pharmaceuticals, Inc.

CIK 0001729427

Entity typeother

Related Parties

1
  • filerCIK 0001853985

Filing Metadata

Form type
4
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 9:50 PM ET
Size
7.9 KB